Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: June 2014

2 - Excessive menstrual bleeding

References

1. NoyesRW, HertigAT, RockJ. Dating the endometrial biopsy. Fertil Steril 1950;1:3–25.
2. TalbiS, HamiltonAE, VoKC, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology 2006;147:1097–121.
3. HabibaMA, BellSC, Al-AzzawiF. Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium. Hum Reprod 1998;13:1674–82.
4. CritchleyHO, BrennerRM, HendersonTA, et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 2001;86:1370–8.
5. BrennerRM, NayakNR, SlaydenOD, CritchleyHO, KellyRW. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann N Y Acad Sci 2002;955:60–74; discussion 86, 396–406.
6. MarkeeJE. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contributions to Embryology 1940;28:219–308.
7. CritchleyHO, KellyRW, BrennerRM, BairdDT. The endocrinology of menstruation – a role for the immune system. Clin Endocrinol (Oxf) 2001;55:701–10.
8. FraserIS, CritchleyHO, MunroMG, BroderM. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?Hum Reprod 2007;22:635–43.
9. National Institute for Health and Clinical Excellence. Heavy Menstrual Bleeding: Investigation and Treatment. Clinical guideline 44. London: NICE: 2007 [http://www.nice.org.uk/guidance/CG44].
10. PrenticeA. Health burden of menstrual disorders. In: O’BrienS, CameronI, MacLeanA (editors). Disorders of the Menstrual Cycle. London: RCOG Press; 2000. pp. 171–86.
11. ReidPC, Virtanen-KariS. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005;112:1121–5.
12. HallbergL, HogdahlAM, NilssonL, RyboG. Menstrual blood loss – a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966;45:320–51.
13. FraserIS, PearseC, ShearmanRP, ElliottPM, McIlveenJ, MarkhamR. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 1981;58:543–51.
14. HighamJM, O’BrienPMS, ShawRM. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734.
15. MunroMG, CritchleyHO, FraserIS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them?Am J Obstet Gynecol 2012;207:259–65.
16. JabbourHN, SalesKJ, SmithOP, BattersbyS, BoddySC. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006;252:191–200.
17. KouidesPA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol 2001;14:381–99.
18. LukesAS, KadirRA, PeyvandiF, KouidesPA. Disorders of hemostasis and excessive menstrual bleeding: prevalence and clinical impact. Fertil Steril 2005;84:1338–44.
19. LivingstoneM, FraserIS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002;8:60–7.
20. FraserIS, McCarronG, MarkhamR, RestaT, WattsA. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet Gynecol 1986;68:630–3.